Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine as Adjuvant to Caudal Bupivacaine in Hypospadius Repair
NCT03476772Completed
- Sponsor
- Assiut University
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of nalbuphine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: post operative pain measurement at 24 hours. Started Mar 2018; status: completed.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03476772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03476772.